Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A research consortium in which Professor Anna Gloyn is a member has been awarded EU funding of €5.99 million as part of the Horizon 2020 Research and Innovation Framework Progamme.

The consortium which involves eleven partners will “Develop a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes -T2DSystems”.